BUSINESS

Tarsus Pharmaceuticals Buys iRenix Medical to Expand Eye Care Pipeline

Tarsus acquires iRenix Medical and its late-stage asset IRX-101, targeting vision loss for millions of patients.

GlobalNewswire
EDITOR'S PICKS

Markets

View all 6 →

Economy

View all 1 →

Business

View all 6 →

Personal Finance

View all 1 →
MOST READ
  1. 1 BUSINESS

    Tarsus Pharmaceuticals Buys iRenix Medical to Expand Eye Care Pipeline

  2. 2 MARKETS

    BofA Says Nvidia Stock Is Discounted and Worth Buying Now

  3. 3 MARKETS

    SpaceX Bitcoin Wallet Stirs After Six Months of Silence

  4. 4 MARKETS

    BNB Chain Plans New Layer-1 Blockchain for High-Speed Trading

  5. 5 MARKETS

    BNB Chain Plans New Layer-1 Blockchain for High-Frequency Trading

Stay informed.

One concise briefing, weekly. No spam.

By subscribing you agree to receive periodic communications. Unsubscribe anytime via the link in each message or our Unsubscribe page.